aap Implantate AG - Asset Resilience Ratio
aap Implantate AG (AAQ1) has an Asset Resilience Ratio of 3.55% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how aap Implantate AG's Asset Resilience Ratio has changed over time. Check asset allocation strategy of aap Implantate AG to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down aap Implantate AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see aap Implantate AG market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €497.00K | 3.55% |
| Total Liquid Assets | €497.00K | 3.55% |
Asset Resilience Insights
- Limited Liquidity: aap Implantate AG maintains only 3.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
aap Implantate AG Industry Peers by Asset Resilience Ratio
Compare aap Implantate AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for aap Implantate AG (2016–2024)
The table below shows the annual Asset Resilience Ratio data for aap Implantate AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.48% | €392.00K ≈ $458.29K |
€15.84 Million ≈ $18.52 Million |
+0.37pp |
| 2023-12-31 | 2.10% | €363.00K ≈ $424.39K |
€17.28 Million ≈ $20.20 Million |
+0.78pp |
| 2022-12-31 | 1.32% | €268.00K ≈ $313.32K |
€20.23 Million ≈ $23.65 Million |
+0.49pp |
| 2021-12-31 | 0.83% | €191.00K ≈ $223.30K |
€22.95 Million ≈ $26.84 Million |
-0.65pp |
| 2020-12-31 | 1.48% | €292.00K ≈ $341.38K |
€19.71 Million ≈ $23.04 Million |
-3.34pp |
| 2019-12-31 | 4.82% | €1.27 Million ≈ $1.48 Million |
€26.29 Million ≈ $30.73 Million |
-1.93pp |
| 2018-12-31 | 6.75% | €2.85 Million ≈ $3.33 Million |
€42.22 Million ≈ $49.36 Million |
+0.80pp |
| 2017-12-31 | 5.95% | €3.00 Million ≈ $3.51 Million |
€50.47 Million ≈ $59.00 Million |
+0.20pp |
| 2016-12-31 | 5.74% | €3.67 Million ≈ $4.29 Million |
€63.85 Million ≈ $74.65 Million |
-- |
About aap Implantate AG
aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials. The company sells its products directly to hospitals, purchasing groups, and hospital… Read more